Invesco Pharmaceuticals ETF
PJP
96 hedge funds and large institutions have $85.6M invested in Invesco Pharmaceuticals ETF in 2018 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 28 reducing their positions, and 12 closing their positions.
42% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 12
4% more funds holding
Funds holding: 92 → 96 (+4)
1.91% more ownership
Funds ownership: 13.59% → 15.5% (+1.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $87.7M → $85.6M (-$2.14M)
32% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Madison Investment Holdings
Madison,
Wisconsin
|
+$2.14M |
| 2 |
FSA
Financial Sense Advisors
San Diego,
California
|
+$1.98M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.44M |
| 4 |
FWM
Focused Wealth Management
Newburgh,
New York
|
+$1.35M |
| 5 |
PSF
Pacific Sun Financial
Los Angeles,
California
|
+$898K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$2.49M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.79M |
| 3 |
Morgan Stanley
New York
|
-$1.78M |
| 4 |
TSS
Two Sigma Securities
New York
|
-$1.04M |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$426K |
PJP Hedge Fund Activity: Q1 2018 in Review
96 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2018, worth a combined $85.6M — down 2.4% from $87.7M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new PJP positions and 12 closed out — a net gain of 5 holders — while 19 added to existing stakes and 28 trimmed.
The largest buyer was Madison Investment Holdings, opening a new position worth an estimated $2.14M. The largest seller was Bank of America, cutting an estimated $2.49M.
- 96 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2018, up from 92 in Q4 2017.
- Funds reported $85.6M of Invesco Pharmaceuticals ETF stock for Q1 2018, down 2.4% quarter-over-quarter.
- 17 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2018 and 12 closed out, a net change of +5 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q1 2018 was Madison Investment Holdings, an estimated $2.14M added.
- The largest Invesco Pharmaceuticals ETF seller in Q1 2018 was Bank of America, an estimated $2.49M sold.
Based on aggregated 13F filings for Q1 2018.